Horizon Trials simplifies your search for clinical trials by matching you with the latest treatments tailored to your condition, medical history, and other key factors. Our AI-powered algorithm connects you to clinical trial research centers across Canada, saving you time and effort.
At Horizon Trials, we leverage years of clinical research and medical technology experience to simplify and enhance clinical trial management. Our AI-driven platform streamlines participant recruitment, inspired by our founders’ firsthand encounters with delays in finding life-saving treatments. We’re dedicated to making trials more accessible, efficient, and impactful for both researchers and patients.
Embark on your journey to health and healing with Horizon Trials. Here’s how our platform works for you.
Horizon Trials lets you update your medical profile, while our AI analyzes it to match you with suitable clinical trials.
Our algorithm finds new trials for your condition and sends real-time notifications, helping you take charge of your wellness.
Our AI connects you to tailored clinical trials and exclusive opportunities through industry partnerships.
Monitor your enrollment status and trial updates in one place, staying informed throughout your journey.
Gain access to hidden and exclusive clinical trials
Stay informed with instant notifications about new clinical trial opportunities.
Stay informed with instant notifications about new clinical trial opportunities.
Horizon Trials is launching a program to connect CROs with AI-matched volunteers for their trials. Share your email to get notified at launch.
Explore a wide range of clinical trials designed to match your medical needs and provide access to cutting-edge treatments
University of Alberta
21/01/2021
OPTIMUM is a study designed to compare the ability of ultra-high resolution transrectal micro-ultrasound (microUS) and multiparametric MRI (mpMRI)/US fusion to guide prostate biopsy.
Princess Margaret Cancer Center
05/08/2022
This is a Phase II prospective sing-arm trial that is recruiting 60 participants from patients that have biochemical failure after radical prostatectomy with local or regional recurrence proven by PSMA PET. Participants of this study will receive molecular imaging informed radiation dose escalation to site of recurrent disease and de-escalation to uninvolved areas. Participants will be follow-up as per standard of care up to 5 years post-treatment.
London Health Sciences Centre
04/02/2021
The study is a non-randomized, prospective trial of men scheduled for radical prostatectomy for treatment of prostate cancer as standard of care and will undergo a series of pre-operative multi-modality imaging studies. Pre-operative imaging will be correlated with actual pathology results and statistical modeling performed to determine the most informative imaging biomarkers in predicting cancer location and aggressiveness (Gleason Score).
Explore articles with tips and insights to know your about clinical matching
Clinical trials stand as the bedrock of medical advancement, the crucial process through which innovative treatments are evaluated for safety...
May 5, 2025
Clinical trials are the driving force behind medical innovation, providing crucial data on the safety and effectiveness of new treatments....
February 27, 2025
Clinical trials are the foundation of medical progress, driving innovation in treatments for cancer, chronic diseases, and rare conditions. These...
February 22, 2025
Explore articles with tips and insights to know your about clinical matching
L1N6Y1 / 26
Winston Crescent
Whitby, ON
Canada
